We found that the sensitivity of FDG-PET, but not of CT, was lower in patients who received bevacizumab, although the difference did not reach statistical significance.
← all excerpts
The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings.
1
—
—